Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second Therapeutic Freeze After Salvage Cryoablation for Localized Radiorecurrent Prostate Cancer.

The Prostate·2026
Same author

Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.

The Prostate·2026
Same author

Transcriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data.

Journal of the National Cancer Center·2025
Same author

Small Renal Mass Cryoablation: Trifecta Outcomes of a Single-Institution Experience with a 20-Year Follow-Up.

Cancers·2025
Same author

Comparative Economic Evaluation of Radical Prostatectomy, Radiation, and Ablative Techniques in the Management of Localized Prostate Cancer.

Cancers·2025
Same author

Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancer.

Prostate cancer and prostatic diseases·2025
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease.

The Urologic clinics of North America·2026
Same journal

Surveillance Protocols: Balancing Patient Burden and Cancer Control.

The Urologic clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Oct 30, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K

Genetically Informed Prostate Cancer Screening.

Rohith Arcot1, Todd M Morgan2, Thomas J Polascik1

  • 1Division of Urology, Duke University, 20 Duke Medicine Circle, Durham, NC 27710, USA.

The Urologic Clinics of North America
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

Genetic insights into prostate cancer can refine screening methods. Understanding inherited risks allows for personalized approaches, potentially reducing overdiagnosis and overtreatment associated with current screening protocols.

Keywords:
GeneticsGermline mutationsProstate cancerProstate cancer screeningSingle nucleotide polymorphisms

More Related Videos

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

541
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.8K

Related Experiment Videos

Last Updated: Oct 30, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

541
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

6.8K

Area of Science:

  • Oncology and Genetics

Background:

  • Prostate cancer poses a significant healthcare burden in the US, marked by high incidence, treatment complications, and mortality.
  • Current prostate-specific antigen (PSA) screening is controversial due to overdiagnosis and overtreatment concerns.

Purpose of the Study:

  • To review the genetic underpinnings of prostate cancer.
  • To explore novel, genetically informed, risk-adapted screening strategies.

Main Methods:

  • Literature review of current evidence on the genetic basis of prostate cancer.
  • Analysis of advancements in molecular oncology related to inherited predisposition.

Main Results:

  • Evidence supports an inherited predisposition to prostate cancer.
  • Genetic information can guide individualized, risk-adapted screening.

Conclusions:

  • Genetically informed screening strategies offer a promising approach to mitigate harms of routine screening.
  • Personalized screening based on inherited risk can improve patient outcomes and reduce healthcare burden.